EV/EBITDA
-1.26
0.000.00%
Thu, 02 Jan 2025 22:36:20 GMT
Summary:
TScan Therapeutics EV/EBITDA is currently -1.26, unchanged from the previous trading day. Over the past year, it has increased by +1.64 (+56.55%). TCRX EV/EBITDA is now -166.67% below its all-time high of 1.89.TCRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +42.5% |
| 3 m3 months | +45.7% |
| 6 m6 months | +20.8% |
| ytdytd | 0.0% |
| 1 y1 year | +56.5% |
| 5 y5 years | - |
TCRX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -1.15 | -9.6% | -2.19 | +42.5% |
| 3 m | 3 months | -1.15 | -9.6% | -2.58 | +51.2% |
| 6 m | 6 months | -1.15 | -9.6% | -2.67 | +52.8% |
| 1 y | 1 year | -1.15 | -9.6% | -5.06 | +75.1% |
| 3 y | 3 years | 1.89 | -166.7% | -5.06 | +75.1% |
| 5 y | 5 years | 1.89 | -166.7% | -7.05 | +82.1% |
| alltime | all time | 1.89 | -166.7% | -7.05 | +82.1% |
TScan Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.26(0.0%) |
| 2024 | -1.26(-59.5%) |
| Date | Value |
|---|---|
| 2023 | -3.11(+3355.6%) |
| 2022 | -0.09(-108.6%) |
| 2021 | 1.05 |
FAQ
- What is TScan Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TScan Therapeutics?
- What is TCRX EV/EBITDA year-to-date change?
- What is TScan Therapeutics EV/EBITDA year-on-year change?
What is TScan Therapeutics EV/EBITDA?
The current EV/EBITDA of TCRX is -1.26
What is the all time high EV/EBITDA for TScan Therapeutics?
TScan Therapeutics all-time high EV/EBITDA is 1.89
What is TCRX EV/EBITDA year-to-date change?
TScan Therapeutics EV/EBITDA has changed by 0.00 (0.00%) since the beginning of the year
What is TScan Therapeutics EV/EBITDA year-on-year change?
Over the past year, TCRX EV/EBITDA has changed by +1.64 (+56.55%)